Carolyn Ho, MD
Medical Director, Cardiovascular Genetics Center, Brigham and Women’s Hospital, Harvard Medical School
The Hypertrophic Cardiomyopathy (HCM) Education Series brings together leaders in the field to share best practices on HCM diagnosis, treatment and management – including the impact of artificial intelligence (AI) on the HCM workflow.
This session aims to assist learners to identify the genetic factors that influence disease expression and clinical outcomes; understand the process to clinically implement genetic testing in HCM to develop more personalized, precise, and proactive management plans for patients and families with HCM; and understand the roles, advantages, and limitations of the clinical examination, ECG, echocardiography, Cardiovascular magnetic resonance imaging (CMR).
